BR9606691A - Composto de 5-etoxicarbonil-2,4,6-trimetil-1,4-diidropiridina-3-car boxilato de 2- n-(1,2-benzisotiasolil-3 (2h) ona- 1,1- dióxido etila - Google Patents

Composto de 5-etoxicarbonil-2,4,6-trimetil-1,4-diidropiridina-3-car boxilato de 2- n-(1,2-benzisotiasolil-3 (2h) ona- 1,1- dióxido etila

Info

Publication number
BR9606691A
BR9606691A BR9606691-1A BR9606691A BR9606691A BR 9606691 A BR9606691 A BR 9606691A BR 9606691 A BR9606691 A BR 9606691A BR 9606691 A BR9606691 A BR 9606691A
Authority
BR
Brazil
Prior art keywords
ona
trimethyl
benzisothiasolyl
dihydropyridine
ethoxycarbonyl
Prior art date
Application number
BR9606691-1A
Other languages
English (en)
Inventor
Carlos Sunkel Letelier
Francisco Javier Ciller Corral
Miguel Fau De Casajuana Mu Oz
Pilar Ortega Navarrete
Jaime Priego Fernandez D Campo
Luis Santos Gil
Original Assignee
Alter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alter Lab filed Critical Alter Lab
Publication of BR9606691A publication Critical patent/BR9606691A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção de ""COMPOSTO DE 5-ETOXICARBONIL-2,4,6-TRIMETIL-1,4,-DIIPROPIRIDINA-3-CAR BOXILATO DE 2-[N-(1,2-BENZISO-TIAZOLIL-3 (2H) ONA-1,1- DIóXIDO]ETILA. A invenção revela essencialmente a aplicação de dito produto como agente terapêutico para tratar pacientes que sofrem de aterosclerose e/ou reestenose e que incorrem em sério risco de oculsão dos vasos afetados pelas moléstias. Dita substância pode ser administradora pela boca ou via parenteral, associada ou não com outras drogas, a pacientes sofrendo de aterosclerose para reduzir ferimento ateromatoso e prevenir a reestenose dos vasos sanguíneos.
BR9606691-1A 1995-08-25 1996-08-20 Composto de 5-etoxicarbonil-2,4,6-trimetil-1,4-diidropiridina-3-car boxilato de 2- n-(1,2-benzisotiasolil-3 (2h) ona- 1,1- dióxido etila BR9606691A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95500122A EP0771560A1 (en) 1995-08-25 1995-08-25 Use of 2- N-(1,2-benzoisothiazolyl-3(2H)one-1,1-dioxide ethyl 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropiridine-3-carboxylate in the treatment of vascular disorders
PCT/ES1996/000160 WO1997007801A1 (es) 1995-08-25 1996-08-20 Nuevas aplicaciones del 5-etoxicarbonil-2,4,6-trimetil-1,4-dihidropiridina-3-carboxilato de 2-[n-(1,2-benzisotiazolil-3(2h)ona-1,1-dioxido]etilo

Publications (1)

Publication Number Publication Date
BR9606691A true BR9606691A (pt) 2000-05-09

Family

ID=8221657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606691-1A BR9606691A (pt) 1995-08-25 1996-08-20 Composto de 5-etoxicarbonil-2,4,6-trimetil-1,4-diidropiridina-3-car boxilato de 2- n-(1,2-benzisotiasolil-3 (2h) ona- 1,1- dióxido etila

Country Status (12)

Country Link
EP (1) EP0771560A1 (pt)
JP (1) JPH10508879A (pt)
KR (1) KR970706817A (pt)
AU (1) AU6931496A (pt)
BR (1) BR9606691A (pt)
CA (1) CA2203624A1 (pt)
EA (1) EA199700053A1 (pt)
HU (1) HUP9701695A3 (pt)
IL (1) IL120718A0 (pt)
MX (1) MX9703032A (pt)
WO (1) WO1997007801A1 (pt)
ZA (1) ZA967223B (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten

Also Published As

Publication number Publication date
IL120718A0 (en) 1997-08-14
HUP9701695A3 (en) 1999-10-28
CA2203624A1 (en) 1997-03-06
HUP9701695A2 (hu) 1998-03-30
KR970706817A (ko) 1997-12-01
JPH10508879A (ja) 1998-09-02
AU6931496A (en) 1997-03-19
ZA967223B (en) 1997-03-03
WO1997007801A1 (es) 1997-03-06
EA199700053A1 (ru) 1997-12-30
EP0771560A1 (en) 1997-05-07
MX9703032A (es) 1997-12-31

Similar Documents

Publication Publication Date Title
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
WO2001009118A3 (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
FR2713635B1 (fr) Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DK1137762T3 (da) Behandling af Pompes sygdom
WO2004001383A3 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
DE69830512D1 (de) Heilmittel für neurodegenerative krankheiten
BR9807673A (pt) Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica.
FR2721516B1 (fr) Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
BR9913955A (pt) Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular
MX9708800A (es) Compuestos biciclicos aromaticos.
PL320687A1 (en) Use of incense for treating alzheimer disease
FR2713637B1 (fr) Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
HUP0002836A2 (hu) Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
SE9902597D0 (sv) New use
HUP0003256A2 (hu) Pentozán-poliszulfát és sói alkalmazása krónikus progresszív érhegesedéssel járó betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
BR9606691A (pt) Composto de 5-etoxicarbonil-2,4,6-trimetil-1,4-diidropiridina-3-car boxilato de 2- n-(1,2-benzisotiasolil-3 (2h) ona- 1,1- dióxido etila
KR930019224A (ko) 유산 위험 치료제
BR0008703A (pt) Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência
EE04040B1 (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law